States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, ...

A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical ...

Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Annalisa (Nalis) Merelli is ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

AstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...